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Enteric infections and diarrheal diseases constitute pervasive health burdens throughout
the world, with rates being highest at the two ends of life. During the first 2–3
years of life, much of the disease burden may be attributed to infection with enteric
pathogens including Salmonella, rotavirus, and many other bacterial, viral, and protozoan
organisms; however, infections due to Clostridium difficile exhibit steady increases with
age. Still others, like Campylobacter infections in industrialized settings are high in
early life (<2 years old) and increase again in early adulthood (called the “second
weaning” by some). The reasons for these differences undoubtedly reside in part in
pathogen differences; however, host factors including the commensal intestinal microbial
communities, immune responses (innate and acquired), and age-dependant shifts likely
play important roles. Interplay of these factors is illustrated by studies examining changes
in human gut microbiota with inflammatory bowel disease and irritable bowel syndrome.
Recent gut microbial surveys have indicated dramatic shifts in gut microbial population
structure from infants to young adults to the elders. An understanding of the evolution
of these factors and their interactions (e.g., how does gut microbiota modulate the
“inflamm-aging” process or vice versa) through the human life “cycle” will be important in
better addressing and controlling these enteric infections and their consequences for both
quality and quantity of life (often assessed as disability adjusted life-years or “DALYs”).
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DEFINING ENTERIC “DISEASE”
Defining “pathogens” first requires defining “disease.” We pro-
pose defining enteric disease as far more than simply passage of
unformed stools (i.e., “diarrhea”) from one end of a very long and
functionally critical “tube” to sustaining healthy life. Therefore, a
broader definition of enteric disease would include: ≥3 or more
unformed stools per day and any documented intestinal infec-
tion associated with disrupted intestinal absorptive and/or barrier
function. This may impair growth in young children or cognitive
function. Implicit in this more comprehensive concept of enteric
disease is an urgent need for improved biomarkers of impaired
intestinal absorptive and barrier function.
Thus, an enteric pathogen may be classified as any microbe
that is able to cause enteric “disease” as defined above. Microbial
pathogenesis can involve direct invasion, signals triggering host
inflammation or other changes, or secreted factors that damage
the host directly (e.g., toxins), indirectly (e.g., microbial compe-
tition), and/or by exploiting other environmental host-associated
factors to thrive.
HOST LOCALE OF ENTERIC DISEASE
The intestinal epithelium is a heterogeneous mixture of cells
poised to respond to the closely positioned microbiota and lumi-
nal contents. The tight junctions that exist between intestinal
epithelial cells provide a maintained barrier (Marchiando et al.,
2010) that when breached by enteric pathogen or toxin can
lead to leakage of luminal contents into the underlying lamina
propria where immune cells reside and potentially instigate dele-
terious inflammatory and other physiological responses leading
to diarrhea or disrupted absorptive function (Su et al., 2009).
Conversely, nutritional status, intestinal microbiota, and stress
have been shown to play roles in maintaining barrier function
(Brewster et al., 1997; Yang et al., 2006; Zareie et al., 2006).
Perturbations of nutritional status and alteration of the intestinal
microbiota is evident in persistent malnutrition and enteric infec-
tions (Mondal et al., 2012). Changes in the intestinal architecture
during a malnourished state include blunted villi, crypt hyper-
trophy, and altered levels of intraepithelial lymphocytes leading
to impaired immune responses, nutrient absorption (Figure 1)
and ultimately decline in early childhood growth (Guerrant et al.,
2008; Moore et al., 2010).
Effects of intestinal flora on the brain and enteric nervous sys-
tem are now being elucidated. Early childhood enteric disease
andmalnutrition have been linked with impaired cognitive devel-
opment (Lorntz et al., 2006; Laus et al., 2011). The profound
effect of childhood malnutrition and enteric disease on cognitive
function ultimately affects individual productivity in life; more-
over, stunting early in life may increase risk for later obesity and
possibly other chronic diseases (Guerrant et al., 2008; Victora
et al., 2008). Factors such as APOE4 may affect enteric disease
and cognitive function. The APOE4 allele in Brazilian children
has been correlated with lower diarrhea burdens, and improved
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FIGURE 1 | Differences between “healthy” and malnourished intestinal
mucosa are represented by architectural changes (villi height/crypt
depth, crypt hypertrophy), molecular changes (tight junction alteration,
nutrient absorption), immune changes, and the intestinal microbiota.
Cross-talk between the intestinal microbiota and intestinal mucosa through
metabolites is unclear.
cognitive performance (Oria et al., 2005); cellular effects of APOE
in the intestine and brain are under study (Vitek et al., 2009;
Azevedo et al., 2012). While APOE4 provides protection to chil-
dren with enteric disease, it is also linked with the neurodegen-
erative, Alzheimer’s disease (Strittmatter et al., 1993). Currently,
no apparent links appear to exist between APOE4 and malnu-
trition in the elderly (Matera et al., 2010); furthermore, limited
studies have found associations between cognitive impairment
and malnutrition or infections in the elderly, although causal-
ity remains unclear (Orsitto et al., 2009; Fagerstrom et al., 2011).
The long-term impact of enteric infections in children is a subject
of intense research; however, parallel studies in elders are lack-
ing. Increasingly, research addressing the connection(s) between
intestine, microbiota, and brain (Grenham et al., 2011) should
illuminate host-microbe processes.
LIFE STAGES, INCIDENCE, PATHOGENS
By expanding the definition of enteric disease, the role of
the host:pathogen (H:P) balance throughout life stages can be
addressed in several contexts. Globally, the highest rates of diar-
rhea mortality tend to occur during early and late-life stages
(Figure 2A; WHOdata); however, rates in countries with the low-
est GNI remain high throughout life. The age-associated trend
is evident in cases of salmonellosis with high indices in infants
and elders ≥65 (Trevejo et al., 2003). E. coli infections impacting
early and late life stages are pathogen dependent; furthermore,
diarrheagenic E. coli segregate geographically (Qadri et al., 2005;
Ochoa et al., 2009; Snedeker et al., 2009; Opintan et al., 2010).
Cryptosporidium may have its greatest impact in children <1yo
or in already stunted children, (Checkley et al., 1997, 1998, 2008;
Putignani and Menichella, 2010) rotaviruses in the first 2 years
of life; Campylobacter in early childhood and young adulthood
(the “second weaning”) (Ailes et al., 2008; da Silva et al., 2010;
Soofi et al., 2011), then C. difficile infections clearly increas-
ing steadily in both frequency and severity with increased age
(Zilberberg et al., 2008). Given age-dependent changes in the
incidence of enteric diseases, additional factors affecting the H:P
balance include: intestinal microbiota, environment/exposure,
and immune response.
AGE-DEPENDENT SHIFTS IN THE INTESTINAL
MICROBIOTA
The gut microbiota play important roles in maintaining the
human health, including energy and nutrient extraction (Deguchi
et al., 1985; Cummings and Macfarlane, 1991, 1997; Turnbaugh
and Gordon, 2009), host immune system modulation and
protection against pathogens (van der Waaij et al., 1971;
Rolfe RD, 1997). Understanding of the diversity of human
gut microbiota has improved dramatically in recent years
largely due to culture-independent 16S rRNA based surveys.
Recent studies have shown large interpersonal variations in
the gut microbiota as a function of age (Figure 3), health
status and diet (Dethlefsen et al., 2006; Ley et al., 2006;
Mueller et al., 2006; Woodmansey, 2007; Tannock, 2008; O’Toole
and Claesson, 2010; Claesson et al., 2011; Wu et al., 2011).
Nevertheless, population based studies show three “enterotypes”
with potential diagnostic value (Arumugam et al., 2011). The
enterotypes are based on the preponderance of three genera:
Bacteroides, Prevotella, and Ruminococcus. It is likely that addi-
tional enterotypes will surface when other health-related factors
are considered (De et al., 2010; Monira et al., 2011; Wu et al.,
2011).
The gut microbiota during early infancy is relatively simple
but highly dynamic (Favier et al., 2002; Palmer et al., 2007).
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FIGURE 2 | Age-dependent mortality rates due to diarrhea (A) or
protein-energy malnutrition (B) based on 2008 WHO data. Numbers of
diarrheal or malnutrition from the Global Burden of Disease in 2008 cases
were compared to the total population sum of each WHO region (2012).
WHO regions were grouped into four categories (i.e., low, low-middle,
upper-middle, and upper) based on Gross National Income (GNI) brackets
established by the World Bank (2012). The GNI income bracket most
represented within a WHO region was used to combine data. For example,
the Region of Americas (AMRB) consists of 26 countries, the majority of
which (n = 18) are classified as upper-middle income countries and were
therefore included in the upper-middle income data. The low-income (red line)
category consists of African Region (AFR D and E) and South East Asian
Region (SEAR D); low-middle (green line) consists of Region of the Americas
(AMR D), Eastern Mediterranean Region (EMR D), Western Pacific Region
(WPR B), and SEAR B; upper-middle (blue line) consists of AMR B, EMR B,
and European Region (EURB and C); upper (grey line) consists of AMR A,
EUR A, and WPR A. The mortality rate data are limited by the use of all-age
population data, so actual age-dependent rates may differ.
FIGURE 3 | Predominant commensal and pathogenic microbes
associated with human life stages. Color intensity of each bar correlates
with presence or absence of commensal bacteria at the phylum (underlined)
with examples listed below using noted references. Studies characterizing
fecal microbiota prior to 2007 quantify the viable counts of bacteria, while
later studies use DNA based methods.
Incidental exposures (e.g., maternal microbiota, breastfeeding
vs. formula) play a major role in seeding the neonatal gut
(Bennet et al., 1991; Mandar and Mikelsaar, 1996; Penders et al.,
2006; Adlerberth and Wold, 2009). As a result, the progression
of early colonization is often chaotic and variable (Palmer
et al., 2007). Facultative anaerobes, like E. coli (Hopkins et al.,
2001; Salminen and Isolauri, 2006; Mariat et al., 2009) and
Gram-negative obligate anaerobes (e.g., Bacteroides-Prevotella)
dominate early followed by a predominance of bifidobacte-
ria by three months of age (Mah et al., 2007; Mariat et al.,
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2009). Infection with Salmonella and pathogenic E. coli pose
the greatest risks in early infancy when facultative anaerobes
are predominant. Over the first year, through a series of suc-
cessions and replacements, the infant microbial communities
become more similar to one another, converging toward a
more stable adult-like profile (Favier et al., 2002; Palmer et al.,
2007), characterized by a preponderance of Bacteroidetes and
Firmicutes. In addition to the composition difference, quan-
titative PCR show total bacterial counts in infants to be
nearly ten-fold lower than in adults and elders (Mariat et al.,
2009).
Gut microbiota in young adults are dominated by
Bacteroidetes and Firmicutes (making up approximately 95%
of the microbiota) with smaller fractions of Actinobacteria and
Proteobacteria (Ley et al., 2006; Andersson et al., 2008; Tap
et al., 2009). The peak numbers and diversity in gut microbial
composition is achieved near the end of adolescence. Still, each
adult’s gut appears to harbor a unique microbial community
that remains relatively stable through adulthood (Franks et al.,
1998; Zoetendal et al., 1998; Vanhoutte et al., 2004; Leser and
Molbak, 2009). One recent study suggested that stability may
last longer than expected, and that aging starts to affect the gut
microbiota after 65 years of age (Biagi et al., 2010). In addition,
decreased intestinal motility (Brocklehurst, 1972; Macfarlane
et al., 1989), dietary changes (Flint et al., 2007), and “inflamm-
aging” (a chronic low-grade inflammation in elders) (Franceschi,
2007; Guigoz et al., 2008) all affect homeostasis of the gut
microbial ecosystem. Recent studies indicate dramatic shifts in
the composition of gut commensals in elders. When elders were
compared to young adults, a decrease in the relative abundance
of Bifidobacteria and Firmicutes was observed, accompanied by a
commensurate increase in Bacteroides and facultative anaerobes
(Hopkins and Macfarlane, 2002; Mariat et al., 2009; Claesson
et al., 2011), although large compositional variations were also
found among elderly individuals and populations (Mueller
et al., 2006; Claesson et al., 2011). The decline in beneficial
bifidobacteria is one of the most marked changes in the aging gut,
manifested in both microbial abundance and species diversity
(Mitsuoka et al., 1974; Benno et al., 1992; Mitsuoka, 1992; He
et al., 2001; Hopkins et al., 2001; Hopkins andMacfarlane, 2002).
Such a population shift could increase the susceptibility of elders
to C. difficile infections (CDI) (Woodmansey, 2007; Guigoz
et al., 2008), as a similar but more pronounced composition
change has been observed in CDI patients (Hopkins et al.,
2001; Hopkins and Macfarlane, 2002). Furthermore, a stable
gut microbiota is crucial in preventing C. difficile overgrowth.
This is supported by studies showing significant reductions in
the microbial diversity in patients with recurrent CDI (Chang
et al., 2008), association of CDI onset with altered microbiota
composition(s) before antibiotic treatment (De La Cochetiere
et al., 2008), and prevention of primary or recurrent CDI
through probiotic therapy or fecal transplantation, respectively
(Hickson et al., 2007; Khoruts et al., 2010). Bifidobacteria and
butyrate-producing bacteria (e.g., Clostridium clusters IV and
XIVa) have been suggested to play important roles in provid-
ing colonization resistance against C. difficile (Fallani et al.,
2006; Rousseau et al., 2011); however, more comprehensive
studies are required to substantiate these claims (Gore et al.,
2008).
In addition to CDI, changes in the gut microbial composition
have been linked to childhood allergies and inflammatory bowel
diseases (IBD). It has been proposed that the gut microbiota
in infants modulates the mucosal immune response to environ-
mental allergens (Tannock, 2007). Interestingly, differences in
the bifidobacterial populations have been associated with atopic
diseases and the allergic status of children (Sepp et al., 1997;
Ouwehand et al., 2001; Gore et al., 2008; Hong et al., 2010). IBD,
such as Crohn’s disease and ulcerative colitis are usually diagnosed
in adolescence or early adulthood. Several lines of evidence sug-
gest a microbial etiology in the development of IBD (D’Haens
et al., 1998; Sellon et al., 1998; Gionchetti et al., 2000; Shen et al.,
2001; Sartor, 2004). Previous studies have led to the hypothesis
that altered gut microflora, excluding a specific pathogen, con-
tribute to the etiology of IBD. Loss of microbial diversity and
richness, especially in members of clostridial cluster IV (e.g.,
Faecalibacterium prausnitzii), was observed in Crohn’s disease
patients (Martinez-Medina et al., 2006; Scanlan et al., 2006; Frank
et al., 2007; Sokol et al., 2008; Cucchiara et al., 2009). An increased
Bacteroidetes:Firmicutes ratio and a predominance of opportunis-
tic Proteobacteria have been reported in pediatric and adult IBD
patients (Cucchiara et al., 2009). However, there is an ongoing
debate on whether these changes are the cause or an effect of the
disease (Sokol et al., 2008; Stecher and Hardt, 2008).
COMMON THEMES OF THE MICROBIOTA
As already mentioned, a loss of species diversity and richness
within the microbiota has been observed in IBD and CDI; in
addition, based on their relative abundance, facultative anaerobes
including members of Proteobacteria appear to thrive. Increased
levels of Proteobacteria are also seen in malnourished children or
in patients with celiac’s disease (Bonventre, 1990; Monira et al.,
2011). On a gross level, these findings also tend to occur with
older age when this microbiota “structure” could alter other
host functions (e.g., immune response). For example, the rel-
ative abundance of Bacteroidetes accounted for <15% of the
intestinal community in 71% of malnourished Bangladeshi chil-
dren compared to >40% relative abundance in 71% of healthy
cases.
EXPOSURE AND HOST RESPONSES
The environment plays a major role in acquisition of the
pathogen; in many cases exposure to contaminated food and/or
water are the main vehicles for pathogen transmission. Globally,
countries in the low and low-middle income brackets face the
highest rates of diarrhea-associated mortalities over much of the
life cycle (Figure 2). The age-dependent mortality due to diarrhea
evident at both ends of the life cycle has dramatic regional differ-
ences impacted in part by socio-economic category (e.g., devel-
oped vs. developing countries). Additional factors likely include
polymicrobial infections, diet, host-microbiota relationship, wan-
ing maternal antibody and other regional specific co-morbidities.
Indeed, this rationale could be applied to similar rates of diarrhea
mortality among elders living inWHO regions falling into upper-
middle and upper income categories in contrast to respective
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regional infant rates. In the case of the USA and Canada (i.e.,
AMRA), infection with C. difficile in healthcare or long-term
care facility environments contribute to age-associated increases
in mortality (Zilberberg et al., 2008). Depending on the set-
ting, a patient may be treated with antibiotics that disrupt the
“normal” microbiota resulting in susceptibility to opportunis-
tic pathogens. Furthermore, prolonged stay within a hospital
environment favors the transfer of nosocomial pathogens, in
particular C. difficile (McFarland et al., 1989).
Conversely, exposure to pathogens in early infancy is great-
est as children are weaned. In areas with high diarrhea bur-
dens, both introduction of weaning foods and cessation of
breastfeeding was associated with increased risk of dehydrat-
ing diarrhea (Guerrant et al., 1983; Fuchs et al., 1996).
Consequently, increased malnutrition-based mortality is coinci-
dent with increased diarrhea mortality (Figure 2B). Adaptations
in host immune responses and intestinal microbiota are cru-
cial for the host to survive constant exposure to malnutrition or
undernutrition and diarrhea disease throughout much of the life
cycle, and these adaptations offer protection in later life when
immune status wanes. In neonates, colonization and stabilization
of intestinal microbial communities is intertwined with immune
system development (Shulzhenko et al., 2011) with similar pro-
cesses, albeit senescent in nature, occuring in elders (Biagi et al.,
2010) suggesting age-dependant alterations of these systems are
closely linked to pathogen resistance/susceptibility.
The innate immune system consists of frontline defenses to
pathogens (Hooper and Macpherson, 2010) with parallel or
subsequent responses by the adaptive arm of the immune sys-
tem. Maturation and senescence of components in the adaptive
immunity have been reviewed elsewhere (Adkins et al., 2004;
Cancro et al., 2009). Antibody-mediated protection in utero and
postpartum occurs through maternal, passive transfer and is
cleared by 5 months of age; the age at which growth short-
falls often start (Victora et al., 2010). The impact of diet affects
the host and subsequent adaptive responses; during malnutri-
tion, both B- and T-cell responses are altered. In young mice
and children, protein energy malnutrition decreases mucosal IgA
responses potentially impacting the course of infection (Green
and Heyworth, 1980; McGee and McMurray, 1988; Oberhelman
et al., 1991). Conversely, patients with little to no IgA due
to common variable immunodeficiency were more likely to
be malnourished (Muscaritoli et al., 2001) suggesting impor-
tant links between the immune system and nutritional sta-
tus, which have been recently tied to the intestinal microbiota
(Shulzhenko et al., 2011). The effect of malnutrition on T-cell
responses during enteric infection have been examined in mice
and humans with divergent results. In mice, tissue IFNγ increased
in response to malnutrition and infection with Cryptosporidium
or Heligmosomoides (Ing et al., 2000; Coutinho et al., 2008).
Other in vivo studies show that protein-energy malnutrition
alone ↑ serum IL-10 and ↓ IFNγ (Hillyer et al., 2007; Monk
and Woodward, 2009) suggesting that infection further alters
the immune response during malnutrition. Isolation and sub-
sequent in vitro activation of CD4+ cells from malnourished or
well-nourished, infected children, resulted in more IL-10 or IFNγ
release characteristic of Th2 or Th1 bias, respectively (Rodriguez
et al., 2005). The infecting pathogen(s) were not classified in
this study, but samples from both gastrointestinal and respiratory
infections were analyzed.
CONCLUSIONS
The process of aging is associated with continuous changes in
environmental exposures that subsequently affect the immune
system and host-associated microbiota. Within the host’s shift-
ing landscape, infections by pathogens that cause enteric disease
likely exploit these shifts with resultant initiation of pathogen-
esis and/or establishment of a mutualistic relationship with the
host (e.g., carrier) leading to potential dissemination of the
pathogen. There is still much to be learned about how life stages
and pertubations shape the gut microbial population, and how
these changes influence health and disease, and predominant
enteric pathogens. For whatever population shifts we can asso-
ciate with disease(s), it is necessary to demonstrate causality
and not a mere effect or unrelated association with the diseases
to fulfill Koch’s postulates. Future insights into the interdepen-
dency between environment-host-microbe will be essential for
development of novel therapeutic approaches that treat or pre-
vent enteric disease. Understanding the roles of these factors
within the host will be complementary to external approaches
(e.g., sanitation, water treatment) for controlling or eradicating
pathogen dissemination.
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